American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
55.53
-0.95 (-1.68%)
Aug 28, 2026, 4:00 PM EDT - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, American Healthcare REIT stock has a consensus rating of "Strong Buy" and an average price target of $63.67. The average 1-year stock price forecast is 14.66% higher than the current stock price, while the lowest is $55 (-0.95%) and the highest is $74 (+33.26%).
Price Target: $63.67 (+14.66%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 9 | 9 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates $63 | Buy | Reiterates | $63 | +13.45% | Aug 21, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $58 → $68 | Buy | Reiterates | $58 → $68 | +22.46% | Aug 19, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $67 → $71 | Buy | Reiterates | $67 → $71 | +27.86% | Aug 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $55 | Buy | Reiterates | $55 | -0.95% | Aug 17, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $56 → $61 | Buy | Maintains | $56 → $61 | +9.85% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
2.79B
from 2.26B
Increased by 23.73%
Revenue Next Year
3.20B
from 2.79B
Increased by 14.60%
EPS This Year
0.55
from 0.68
Decreased by -19.33%
EPS Next Year
0.99
from 0.55
Increased by 80.00%
EPS based on non-GAAP adjusted numbers.